NAMA
SRTA

Nikko Asset Management Americas’s Strata Critical Medical Inc SRTA Stock Holding History

Nikko Asset Management Americas’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.2M Sell
989,100
-665,261
-40% -$3.5M 0.07% 104
2026
Q1 		$6.9M Sell
1,654,361
-23,187
-1% -$112K 0.1% 99
2025
Q4 		$8.05M Sell
1,677,548
-151,073
-8% -$731K 0.09% 95
2025
Q3 		$9.22M Sell
1,828,621
-1,170,571
-39% -$5.17M 0.09% 95
2025
Q2 		$12.1M Hold
2,999,192
– – 0.12% 85
2025
Q1 		$8.16M Sell
2,999,192
-101,481
-3% -$364K 0.11% 88
2024
Q4 		$13.1M Sell
3,100,673
-652,145
-17% -$2.48M 0.14% 79
2024
Q3 		$11M Sell
3,752,818
-284,695
-7% -$906K 0.13% 85
2024
Q2 		$14M Buy
4,037,513
+358,539
+10% +$1.2M 0.16% 77
2024
Q1 		$10.4M Sell
3,678,974
-295,318
-7% -$911K 0.1% 84
2023
Q4 		$14M Sell
3,974,292
-285,969
-7% -$821K 0.13% 78
2023
Q3 		$11M Sell
4,260,261
-264,831
-6% -$930K 0.13% 83
2023
Q2 		$17.7M Sell
4,525,092
-257,547
-5% -$817K 0.19% 73
2023
Q1 		$15.8M Sell
4,782,639
-58,776
-1% -$240K 0.18% 65
2022
Q4 		$17.3M Sell
4,841,415
-32,366
-0.7% -$138K 0.25% 63
2022
Q3 		$19.5M Sell
4,873,781
-53,754
-1% -$276K 0.25% 66
2022
Q2 		$21.4M Buy
4,927,535
+50,669
+1% +$366K 0.26% 63
2022
Q1 		$39M Buy
4,876,866
+544,092
+13% +$3.82M 0.29% 66
2021
Q4 		$38.5M Buy
4,332,774
+1,075,940
+33% +$10.2M 0.2% 80
2021
Q3 		$34.7M Buy
3,256,834
+1,604,814
+97% +$14M 0.15% 85
2021
Q2 		$17.5M Buy
1,652,020
+717,064
+77% +$7.08M 0.07% 104
2021
Q1 		$9.62M Buy
934,956
+919,355
+5,893% +$12.8M 0.05% 139
2020
Q4 		$173K Buy
+15,601
New +$159K ﹤0.01% 212

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nikko Asset Management Americas's SRTA Position: Q2 2026 in Review

Nikko Asset Management Americas reduced its Strata Critical Medical Inc (SRTA) stake by 40% in Q2 2026, selling an estimated $3.5M and leaving 989,100 shares worth $5.2M. The position accounts for 0.07% of the portfolio, ranked #104.

Nikko Asset Management Americas first reported a position in SRTA in Q4 2020 and has held it in 23 quarters since. The position peaked at $39M in Q1 2022. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Nikko Asset Management Americas held 989,100 shares of Strata Critical Medical Inc worth $5.2M as of Q2 2026.
  • Nikko Asset Management Americas sold 665,261 Strata Critical Medical Inc shares in Q2 2026, an estimated $3.5M.
  • Strata Critical Medical Inc made up 0.07% of Nikko Asset Management Americas's portfolio in Q2 2026, its #104 holding.
  • Nikko Asset Management Americas first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 23 quarters since.
  • Nikko Asset Management Americas's Strata Critical Medical Inc position peaked at $39M in Q1 2022.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.